Home / Registry / Metagenomics.asia
Available for Acquisition In Stock
Metagenomics.asia

The domain name Metagenomics.asia is officially available for purchase under registry record RR-A1B2-C3D4. RationalRegistry facilitates the formal transfer of legal title and ensures the asset is successfully delivered to the purchaser. All transaction funds are held by a secure escrow service of your choice to guarantee that the interests of both parties are protected throughout the entire process.

Acquisition Enquiry
$9,800
Asking price · USD

Formal response within one business day.

Asset Overview
Asking Price $9,800Audited Valuation
Settlement Secure Escrow Licensed Third-Party
Response < 24 Hours Business Enquiries
Asset Tenure Perpetual Ownership Rights
Registry Asset Record
Date of Record 05 Apr 2026 Archival Entry
Registry ID RR-A1B2-C3D4 Formal Record Entry
Asset Family .asia Regional TLD
Primary Sector Health and Life Sciences Microbial Genomics Research
Linguistic Scarcity Strategic High Scarcity
Market Signals metagenomicsmicrobiomegenomic sequencingmicrobial ecologyDNA analysis Semantic Acquisition Indicators
Rational Choice Evaluation
Market Signal
Costly signals reduce buyer uncertainty in asymmetric markets. A premium domain name functions as a verifiable commitment device.
9 / 10
Linguistic Scarcity
Premium names are finite. Supply is structurally fixed as demand expands, creating durable appreciation pressure.
9 / 10
Recall Efficiency
Memorability reduces search cost at every customer acquisition event, compounding brand value over time.
8 / 10
Economic Utility
Multi-functional capacity to anchor identity, reduce price elasticity, and lower customer acquisition cost across channels.
9 / 10
Strategic Longevity
Preserves the right to exploit future conditions across market cycles. Asset value is not dependent on any single use case.
9 / 10
Composite Score
Arithmetic mean across all five rational choice criteria. Reflects the overall investment grade of the asset.
8.8 / 10
Asset Audit

Metagenomics.asia is audited as a Strategic health asset anchoring the metagenomics and microbial genomics namespace across Asian research and clinical markets. Metagenomics, the direct sequencing of genetic material from environmental or clinical samples without culture, represents the foundational methodology driving microbiome research, infectious disease diagnostics, and agricultural biotechnology. Asia is the primary growth region for metagenomics adoption: China, Japan, South Korea, and India collectively host the largest density of genomics research institutes outside Europe and North America. The Brand Education Cost for metagenomics-focused organisations is negligible among target audiences, as the term carries universal recognition across life sciences, clinical diagnostics, and agricultural biotechnology sectors. Positional Advantage accrues from occupying the exact disciplinary label as a domain: no equivalent regional authority exists under .asia. Institutional acquirers include genomics sequencing service providers, clinical microbiome diagnostics companies, agricultural biotechnology firms, and pan-Asian genomics research consortia. Metagenomics.asia holds Category Ownership Authority over the metagenomics and microbial genomics sector in the Asia-Pacific region.

Metagenomics.asia applies the .asia extension's regional authority to the discipline of environmental and clinical genomic sequencing. The .asia extension provides direct geographic disambiguation for organisations operating across Asia-Pacific genomics markets, reducing Search Costs for institutional buyers and research partners evaluating regional sequencing service providers. The Trust Premium associated with an exact-match disciplinary domain is highest in scientific and clinical sectors, where naming precision directly signals technical credibility. Metagenomics.asia delivers this Trust Premium at the category level, establishing Sector Authority Signal for any operator in microbial genomics, clinical metagenomics, or microbiome analytics across Asian markets.